Trials / Completed
CompletedNCT01417078
A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode
An Open-Label Study to Determine the Pharmacokinetics of a Single Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode for Which Acute Treatment With a Benzodiazepine is Clinically Indicated
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Acorda Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the pharmacokinetics of Diazepam Nasal Spray following a single dose in epileptic patients experiencing a seizure episode.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diazepam | single-dose; dosage in mg, based on patient body weight |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-02-01
- Completion
- 2013-03-01
- First posted
- 2011-08-16
- Last updated
- 2017-03-29
- Results posted
- 2017-03-29
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01417078. Inclusion in this directory is not an endorsement.